Germany· DE-A57-d8bf05d528d6a06a
Budesonid Smartpractice Europe
A budesonide product containing budesonide, registered in Germany by Smartpractice Europe Gmbh. The same ATC class is registered in 2 of our 19 countries.
Checked against EMA Article 57 (European Union) on
Informational only — not a medical device.
Where it is registered
Budesonide is registered in 2 of 19 countries.
Countries holding a registration under ATC D07AC09 (budesonide), each read from that country’s own register.
- This record: Germany, from EMA Article 57 (European Union)
- 1 of them publish a price we can compare per daily dose
Budesonide · ATC D07AC09
2 / 19 countries
- Finlandprice
- Germany
The record
At a glance
EMA Article 57 (European Union)- Active substance
- Budesonide
- Manufacturer
- Smartpractice Europe Gmbh
- Country
- Germany (DE)
- ATC code
- D07AC09
- ATC class
- Budesonide
- Reimbursed
- Not published by this register
- Source register
- EMA Article 57 (European Union)
- Last checked
- September 30, 2026
Packs & prices · 0
No packs listed by the register for this record.
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Budesonide in 16 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- United KingdomAircort 100micrograms/dose nasal sprayImported (Italy)
- United StatesbudesonideREMEDYREPACK INC.
- SwedenBudaxiro 3 mg Kapsel med modifierad frisättning, hårdMedical Valley Invest AB
- FinlandBudenofalkDr. Falk Pharma GmbH
- CzechiaBUDENOFALKDr. Falk Pharma GmbH, Freiburg
- BelgiumAirbufo Forspiro 160 µg/dose - 4.5 µg/doseSandoz
- PolandBDS NAurovitas Pharma Polska Sp. z o.o.
- NetherlandsBudenofalk 4 mg zetpillenMedcor Pharmaceuticals B.V.
Authorised across Europe · EMA
The same active substance is authorised in 30 EEA countries. Names it is sold under:
- Austria · Budenofalk, Budo-San
- Belgium · Budenofalk, Budesonid Sandoz
- Bulgaria · Airbudenid, Буденофалк
- Cyprus · Axelovert, Biosonide
- Czechia · Budenofalk, Budenofalk Uno
- Denmark · Benarhin, Budenofalk
- Estonia · Budesonid Sandoz, Budesonide
- Spain · Budena, Budesonida
- Finland · Budenofalk, Budesonid Easyhaler Orion
- France · Budésonide Arrow, Budesonide Biogaran
- United Kingdom (Northern Ireland) · Benacort, Benacort Hayfever Relief For Adults
- Greece · Aurid, Axelovert
- Croatia · Budelin Novolizer, Budosan
- Hungary · Budenofalk, Budesonid Easyhaler
- Ireland · Budenofalk, Budesonide Azure
- Iceland · Budesonide Stada, Cortiment
- Italy · Aircort, Bidien
- Liechtenstein · Jorveza, Kinpeygo
- Lithuania · Budenofalk, Budesonide Ferring
- Luxembourg · Budenofalk, Budesonide Eg
- Latvia · Budenofalk, Budesonid Sandoz
- Malta · Budesonida Aldo-Unión, Budesonide Azure
- Netherlands · Budenofalk, Budenofalk Schuim
- Norway · Budenofalk, Budesonid Medical Valley
- Poland · Bds N, Benodil
- Portugal · Aeromax, Budenofalk
- Romania · Budenofalk, Budenofalk Uno
- Sweden · Budaxiro, Budenofalk
- Slovenia · Budenofalk, Budesonid Easyhaler Orion
- Slovakia · Budelin Novolizer, Budenofalk
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of EMA Article 57 (European Union). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/ba2a8781-3831-4e9f-835d-3a0a6d5df791 GET /v1/drugs/ba2a8781-3831-4e9f-835d-3a0a6d5df791?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"pzn": null,
"route": "Cutaneous Use",
"source": "ema_art57_de",
"ma_number": null,
"substance": "Budesonide",
"atc_from_source": null,
"authorisation_country": "Germany"
}See everything about budesonide.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.